278 related articles for article (PubMed ID: 17157920)
1. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels.
Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B
Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920
[TBL] [Abstract][Full Text] [Related]
2. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
Fleischhaker C; Schulz E; Remschmidt H
J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
[TBL] [Abstract][Full Text] [Related]
3. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
[TBL] [Abstract][Full Text] [Related]
4. Changes in platelet monoamine oxidase activity, cholesterol levels and hyperactive behaviour in adolescents over a period of three years.
Kiive E; Merenäkk L; Harro M; Harro J
Neurosci Lett; 2005 Aug; 384(3):310-5. PubMed ID: 15921854
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological function and platelet monoamine oxidase activity levels in type I alcoholic patients.
Pombo S; Levy P; Bicho M; Ismail F; Cardoso JM
Alcohol Alcohol; 2008; 43(4):423-30. PubMed ID: 18408241
[TBL] [Abstract][Full Text] [Related]
6. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
[TBL] [Abstract][Full Text] [Related]
7. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
8. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients.
Pivac N; Mück-Seler D; Sagud M; Jakovljević M; Mustapić M; Mihaljević-Peles A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):759-65. PubMed ID: 12921906
[TBL] [Abstract][Full Text] [Related]
9. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
10. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
Fleischhaker C; Schulz E; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin concentration and monoamine oxidase activity in hypothyroid patients.
Stipcevic T; Kusacic-Kuna S; Dezeljin M; Dodig D; Korsic M; Pivac N; Muck-Seler D
Horm Res; 2009; 71(4):207-12. PubMed ID: 19258712
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonin and monoamine oxidase in Alzheimer's disease with psychotic features.
Mimica N; Mück-Seler D; Pivac N; Mustapić M; Dezeljin M; Stipcević T; Presecki P; Radonić E; Folnegović-Smalc V
Coll Antropol; 2008 Jan; 32 Suppl 1():119-22. PubMed ID: 18405069
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
16. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
Ma N; Tan LW; Wang Q; Li ZX; Li LJ
Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
[TBL] [Abstract][Full Text] [Related]
17. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
Jackman H; Luchins D; Meltzer HY
Biol Psychiatry; 1983 Aug; 18(8):887-902. PubMed ID: 6615945
[TBL] [Abstract][Full Text] [Related]
18. Platelet serotonin and serum lipids in psychotic mania.
Sagud M; Mihaljevic-Peles A; Pivac N; Jakovljevic M; Muck-Seler D
J Affect Disord; 2007 Jan; 97(1-3):247-51. PubMed ID: 16820211
[TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
Huang LG; Bowden CL
J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
[TBL] [Abstract][Full Text] [Related]
20. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
